Roswell Park Cancer Institute: clinical-trial pipeline
Roswell Park Cancer Institute is the sponsor of 416 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 85 are not yet finished and 2 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 136 |
| Phase 2 | 125 |
| Phase 1 | 102 |
| Phase 1/2 | 33 |
| Early phase 1 | 12 |
| Phase 3 | 5 |
| Phase 4 | 2 |
| Phase 2/3 | 1 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 206 |
| Terminated | 81 |
| Recruiting | 54 |
| Withdrawn or not authorised | 40 |
| Active, not recruiting | 21 |
| Not yet recruiting | 10 |
| Suspended or halted | 4 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 380 |
| Nephrology and urology | 53 |
| Gastroenterology and liver | 36 |
| Women's health and obstetrics | 23 |
| Rare and genetic diseases | 22 |
| Haematology | 18 |
| Metabolic and endocrine (diabetes, obesity) | 12 |
| Infectious disease and vaccines | 10 |
| Musculoskeletal | 10 |
| Dermatology | 9 |
| Cardiovascular | 5 |
| Respiratory | 3 |
Countries
| Country | Trials |
|---|---|
| United States | 397 |
| Netherlands | 1 |
| New Zealand | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-21 | New trial posted | Chatbot Utilization for Pedigree Creation and Cancer Risk Assessment in Cancer Genetic Co… |
| 2026-10-05 | New trial posted | Text Message and Mail Delivery of Tailored Educational Materials to Improve Access to Res… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06871410 | Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leu… | Phase 1 | Recruiting | United States |
| NCT06995508 | Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial | Phase 2 | Recruiting | United States |
| NCT06798701 | Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation | Not applicable | Active, not recruiting | United States |
| NCT06896695 | A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck C… | Not applicable | Recruiting | United States |
| NCT06074666 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3 | Not applicable | Recruiting | United States |
| NCT02334865 | SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalid… | Phase 1 | Active, not recruiting | United States |
| NCT07075705 | Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy | Not applicable | Recruiting | United States |
| NCT06565260 | Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors | Not applicable | Recruiting | United States |
| NCT05651594 | Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Loc… | Phase 2 | Recruiting | United States |
| NCT07887620 | Chatbot Utilization for Pedigree Creation and Cancer Risk Assessment in Cancer Genetic Counseling | Not applicable | Not yet recruiting | United States |
| NCT06816459 | Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults | Early phase 1 | Recruiting | United States |
| NCT03192397 | Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus… | Phase 1/2 | Active, not recruiting | United States |
| NCT06563388 | Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial | Phase 3 | Recruiting | United States |
| NCT07718672 | Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative Radiotherapy for the Trea… | Phase 2 | Recruiting | United States |
| NCT07107139 | Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory a… | Not applicable | Recruiting | United States |
| NCT07167225 | Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use Cigarettes, E-cigarettes and Cannabis (Co-Tox… | Not applicable | Recruiting | United States |
| NCT06821997 | NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar… | Phase 2 | Recruiting | United States |
| NCT06334016 | Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream | Early phase 1 | Not yet recruiting | United States |
| NCT07017829 | GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Ce… | Phase 2 | Recruiting | United States |
| NCT03897270 | Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects | Not applicable | Recruiting | United States |
| NCT04511039 | Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colo… | Phase 1 | Recruiting | United States |
| NCT05893940 | Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients | Not applicable | Recruiting | United States |
| NCT03880422 | Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and No… | Not applicable | Recruiting | United States |
| NCT06833255 | A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cance… | Not applicable | Recruiting | United States |
| NCT05231122 | Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patie… | Phase 2 | Recruiting | United States |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Roswell Park Cancer Institute clinical trials: 85 open, 6 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/roswell-park-cancer-institute/, data as of 2026-10-25.